Last fall, before being named the senior U.S. health official, Robert F. Kennedy Jr. said the Trump administration would liberate Americans from the FDA's "aggressive suppression" of vitamins, dietary ...

HHS secretary Robert F. Kennedy Jr. has been on the receiving end of two heated letters from lawmakers outlining the threats ...

President Donald Trump and Elon Musk have been rapidly firing federal workers with little consideration for which ones are critical to government functioning. The Federal Aviation Administration is ...

President Donald Trump reportedly issued a stringent warning to pharmaceutical companies, advising them to repatriate their ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Novo Nordisk stock ...

The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...

UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key patent expiry, as US hedge fund Citadel took the largest short position ...

In Robert F. Kennedy Jr.’s first interview as secretary of the Department of Health and Human Services, he made multiple ...

The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

HHS Secretary Robert F. Kennedy Jr. plans to axe members of the department’s vaccine-centric panels of outside advisers who he deems to be too cozy with the drug industry.

The pharmaceutical industry is framing itself as a key partner for President Trump and HHS Secretary Robert F. Kennedy Jr. in ...

A meeting of the CDC's Advisory Committee on Immunization Practices (ACIP), which provides guidance on recommended vaccines ...